Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A single patient experience.
Jessica A SlostadPatrick HoverstenCandace L HaddoxKamila CisakJonas PaludoAyalew TefferiPublished in: American journal of hematology (2017)
Keyphrases